West nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays

Journal of Virology

Volumn 75, Issue 9, 2001, Pages 4040-4047

  Davis, B S ^a   Chang, G J J ^a   Cropp, B ^a   Roehrig, J T ^a   Martin, D A ^a   Mitchell, C J ^a   Bowen, R ^a   Bunning, M L ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN M; RECOMBINANT ANTIGEN; RECOMBINANT DNA; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY; IMMUNOGENICITY; MOSQUITO; MOUSE; NONHUMAN; PARASITE CONTROL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOMBINANT PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; CERCOPITHECUS AETHIOPS; COS CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HORSES; MICE; MICE, INBRED ICR; MOLECULAR SEQUENCE DATA; PLASMIDS; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; WEST NILE FEVER; WEST NILE VIRUS;

EID: 0035051928     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.9.4040-4047.2001     Document Type: Article

References (39)

1. A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms
2. Large-scale purification of Japanese encephalitis virus from infected mouse brain for preparation of vaccine
3. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form
4. Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut
5. Update: Surveillance for West Nile virus in overwintering mosquitoes - New York, 2000
6. Update: West Nile virus activity - Northeastern United States, 2000
7. The West Nile virus outbreak of 1999 in New York: The Flushing Hospital experience
8. A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice
9. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses
10. Modulating the immune response to genetic immunization
11. DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus
12. Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization
13. Recovery and identification of West Nile virus from a hawk in winter
14. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin
15. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence
16. West Nile fever - A reemerging mosquito-borne viral disease in Europe
17. Genetic analysis of West Nile New York 1999 encephalitis virus
18. Detection of antiarboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay
19. The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes
20. A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice
21. Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection
22. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States
23. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice
24. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections
25. High-efficiency gene transfer into skeletal muscle mediated by electric pulses
26. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy
27. Detection of yellow fever virus in serum by enzyme immunoassay
28. Flaviviruses
29. Machine learning approaches for the prediction of signal peptides and other protein sorting signals
30. Comparative electrophoretic analysis of the virus proteins of four rhabdoviruses
31. Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus
32. Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses
33. Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein
34. Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies
35. Evaluation of tick-borne encephalitis Dna vaccines in monkeys
36. Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge
37. Electrochemotherapy with cisplatin: Potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients
38. A neurotropic virus isoalted from the blood of anative of Uganda
39. Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile virus infection